Advertisement
-
-
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases
In this Review, the authors argue that the risk of osteoporosis in patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs) is multifactorial, with contributions from iRMD-specific factors, comorbidities, general risk factors and the effects of iRMD therapies such as glucocorticoids.
-
-
25 years of biologic therapy
Biologic therapies with various modes of action have been introduced into the field of rheumatology over the past 25 years, and have revolutionized the treatment and outcomes in many rheumatic diseases. This collection from Nature Reviews Rheumatology brings together articles on biologic therapy in rheumatology, including the latest Reviews and Opinion pieces, as well as popular content from our archives.
Trending - Altmetric
-
High risk of autoimmune diseases after COVID-19
-
IgG4-related disease: an update on pathophysiology and implications for clinical care
-
Small wonder: nanoparticles feed hydroxychloroquine to activated neutrophils
-
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases